tiprankstipranks
Trending News
More News >
Gain Therapeutics, Inc. (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Ownership - Who Owns Gain Therapeutics?

Compare
408 Followers

Gain Therapeutics (GANX) Ownership Overview

3.33%1.66%0.10%1.19%93.72%
3.33%
Insiders
0.10% Other Institutional Investors
1.19% ETFs
93.72% Public Companies and
Individual Investors
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 2.95% of the company’s stock is owned by Institutional Investors, 3.33% is owned by Insiders, and 93.72% is owned by Public Companies and Individual Investors.
The ownership structure of Gain Therapeutics (GANX) stock is a mix of institutional, retail, and individual investors. Approximately 1.76% of the company’s stock is owned by Institutional Investors, 3.33% is owned by Insiders, and 1.19% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
930,784Insider2.42%1,684,719
371,150Institution0.96%671,782
360,547Institution0.94%652,590
304,458Insider0.79%551,069
246,012Institution0.64%445,282
158,155Institution0.41%355,849
87,512Institution0.23%158,397
30,004Institution0.08%54,307
30,000Insider0.08%54,300
14,400Insider0.04%26,064

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
360,547Institution0.94%652,590
246,012Institution0.64%445,282
30,004Institution0.08%54,307
1,011Institution<0.01%1,830

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
371,150Institution0.96%1,195,103
87,512Institution0.23%164,523

FAQ

Who Owns Gain Therapeutics, Inc. (GANX)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 3.33% is held by insiders, and 93.72% is held by retail investors.
    What percentage of Gain Therapeutics, Inc. (GANX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.10% of Gain Therapeutics, Inc. (GANX) stock is held by institutional investors.
      What percentage of Gain Therapeutics, Inc. (GANX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 93.72% of Gain Therapeutics, Inc. (GANX) stock is held by retail investors.
        Who owns the most shares of Gain Therapeutics, Inc. (GANX)?
        Khalid Islam owns the most shares of Gain Therapeutics, Inc. (GANX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.